Mycobacterium phlei cell wall complex directly induces apoptosis in human bladder cancer cells
Authors:
Open Access
- 18 December 1998
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 79 (2) , 229-235
Abstract
Intact mycobacteria and mycobacterial cell wall extracts have been shown to inhibit the growth of human and murine bladder cancer. Their mechanism of action is, however, poorly understood. Mycobacterium phleimycobacterial cell complex (MCC) is a cell wall preparation that has mycobacterial DNA in the form of short oligonucleotides complexed on the cell wall surface. In this study, we have investigated the possibility that MCC has anti-cancer activity that is mediated by two different mechanisms – a direct effect on cancer cell proliferation and viability and an indirect effect mediated by the production of interleukin 12 (IL-12), a cytokine known to possess anti-cancer activity. We have found that, although MCC is a potent inducer of IL-12 and IL-6 synthesis in monocytes and macrophages either in vitro or in vivo, it is unable to induce the synthesis of either IL-12, IL-6 or granulocyte–macrophage colony-stimulating factor (GM-CSF) by the human transitional bladder cancer cell lines HT-1197 and HT-1376. MCC is not directly cytotoxic towards these cancer cells, but induces apoptosis as determined by nuclear DNA fragmentation and by the release of nuclear mitotic apparatus protein. Mycobacterium phlei DNA associated with MCC is responsible for the induction of apoptosis. Our results indicate that MCC directly effects bladder cancer cells by inhibiting cellular proliferation through the induction of apoptosis, and has the potential for an indirect anti-cancer activity by stimulating cancer-infiltrating monocytes/macrophages to synthesize IL-12.Keywords
This publication has 53 references indexed in Scilit:
- Effects of isoniazid on the proliferation and cytokine production of bladder cancer cells in vitro induced by bacille Calmette‐GuérinBritish Journal of Urology, 1997
- Testosterone Supplementation for Hypogonadal Impotence: Assessment of Biochemical Measures and Therapeutic OutcomesJournal of Urology, 1997
- Apoptosis Induced by Interleukin‐12 Measured by DNA Electrophoresis and in Situ End Labeling in LeukemiaAnnals of the New York Academy of Sciences, 1996
- Influence of phospholipid composition on antibody responses to liposome encapsulated protein and peptide antigensVaccine, 1996
- Antiproliferative effects of interleukin-12 treatment on human tumor colony-forming units taken directly from patientsAnti-Cancer Drugs, 1996
- Interleukin-12 an integral cytokine in the immune responseLife Sciences, 1996
- Role of interleukin-12 (IL 12) as an anti-tumour agent: experimental biology and clinical applicationResearch in Immunology, 1995
- HLA‐DR antigen expression and lymphocyte subsets in transitional cell carcinoma of the urinary bladder. An immunohistological study on frozen sectionsThe Journal of Pathology, 1994
- In vitro Effects of High Energy Shock Wave Alone and Combined with Anticancer Drugs on Human Bladder Cancer CellsUrologia Internationalis, 1994
- Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigenNature, 1990